These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 816519)
21. Uptake of tolbutamide by islets of Langerhans and other tissues. Joost HG; Holze S Experientia; 1978 Oct; 34(10):1372-3. PubMed ID: 367810 [TBL] [Abstract][Full Text] [Related]
22. Control of insulin secretion by sulfonylureas, meglitinide and diazoxide in relation to their binding to the sulfonylurea receptor in pancreatic islets. Panten U; Burgfeld J; Goerke F; Rennicke M; Schwanstecher M; Wallasch A; Zünkler BJ; Lenzen S Biochem Pharmacol; 1989 Apr; 38(8):1217-29. PubMed ID: 2650685 [TBL] [Abstract][Full Text] [Related]
23. Effects of tolbutamide on insulin binding to isolated fat cells of the rat. Joost HG; Arend W; Holze SA Biochem Pharmacol; 1982 Apr; 31(7):1227-31. PubMed ID: 7046753 [TBL] [Abstract][Full Text] [Related]
24. Long-term actions of sulfonylureas on (Pro-) insulin biosynthesis and secretion. III. Functional state of isolated pancreatic rat islets after culture in the presence of tolbutamide and glibenclamide. Gonnermann B; Gustson D; Schatz H Horm Metab Res; 1981 Jul; 13(7):411-2. PubMed ID: 6792024 [No Abstract] [Full Text] [Related]
25. Long-term actions of sulfonylureas on (pro-) insulin biosynthesis and secretion: I. Lack of evidence for a compensatory increase in (pro-) insulin biosynthesis after exposure of isolated pancreatic rat islets to tolbutamide and glibenclamide in vitro. Schatz H; Steinle D; Pfeiffer EF Horm Metab Res; 1977 Nov; 9(6):457-65. PubMed ID: 412764 [No Abstract] [Full Text] [Related]
26. Onset and reversibility of changes in secretory function and composition of isolated rat pancreatic islets following long-term administrationof high or low tolbutamide doses. Schauder P; Arends J; Frerichs H Metabolism; 1977 Jan; 26(1):9-15. PubMed ID: 319321 [TBL] [Abstract][Full Text] [Related]
27. Effect of linogliride on hormone release from perfused rat pancreas. Fuel dependence and desensitization by tolbutamide. Ronner P; Cheong E; Khalid P; Tuman RW; Matschinsky FM Diabetes; 1991 Jul; 40(7):878-84. PubMed ID: 2060724 [TBL] [Abstract][Full Text] [Related]
28. Glucagon secretion from the isolated perfused rat pancreas: influenced by the glucose-, tolbutamide- and pancreozymin-mediated release of pancreatic insulin. Fussgänger RD; Goberna R; Laube H; Schröder KE; Straub K; Pfeiffer EF Isr J Med Sci; 1972 Jun; 8(6):768-9. PubMed ID: 4559419 [No Abstract] [Full Text] [Related]
29. Tolbutamide-induced changes of the DNA, protein and insulin content and the secretory activity of isolated rat pancreatic islets. Schauder P; Frerichs H Diabetologia; 1975 Aug; 11(4):301-5. PubMed ID: 1107120 [TBL] [Abstract][Full Text] [Related]
30. Effects of tolbutamide on insulin and glucagon secretion of the isolated perfused rat pancreas. Laube H; Fussgänger R; Goberna R; Schröder K; Straub K; Sussman K; Pfeiffer EF Horm Metab Res; 1971 Jul; 3(4):238-42. PubMed ID: 4256979 [No Abstract] [Full Text] [Related]
31. Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide. Panten U; Zünkler BJ; Scheit S; Kirchhoff K; Lenzen S Diabetologia; 1986 Sep; 29(9):648-54. PubMed ID: 3539682 [TBL] [Abstract][Full Text] [Related]
32. (Pro-) insulin biosynthesis and release of newly synthesized (pro-) insulin from isolated islets of rat pancreas in the presence of amino acids and sulphonylureas. Schatz H; Nierle C; Pfeiffer EF Eur J Clin Invest; 1975 Nov; 5(6):477-85. PubMed ID: 811472 [TBL] [Abstract][Full Text] [Related]
33. Potassium ions and the secretion of insulin by islets of Langerhans incubated in vitro. Howell SL; Taylor KW Biochem J; 1968 Jun; 108(1):17-24. PubMed ID: 4297939 [TBL] [Abstract][Full Text] [Related]
35. Effects of tetracycline and diazepam on insulin secretion and adenylyl cyclase activity of isolated rat islets of Langerhans. El-Denshary ES; Ismail NA; Montague W Diabete Metab; 1977 Mar; 3(1):3-6. PubMed ID: 323087 [TBL] [Abstract][Full Text] [Related]
36. On-line competitive immunoassay based on capillary electrophoresis applied to monitoring insulin secretion from single islets of Langerhans. Tao L; Aspinwall CA; Kennedy RT Electrophoresis; 1998 Mar; 19(3):403-8. PubMed ID: 9551792 [TBL] [Abstract][Full Text] [Related]
37. Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function. Gregorio F; Ambrosi F; Cristallini S; Pedetti M; Filipponi P; Santeusanio F Diabetes Res Clin Pract; 1992 Dec; 18(3):197-206. PubMed ID: 1289021 [TBL] [Abstract][Full Text] [Related]
38. Hyaluronidase-induced inhibition of the insulinotropic action of sulfonylureas, leucine, and glucagon in rodent isolated pancreatic islets. Macchi IA; Zeytinoğlu FN Horm Metab Res; 1976 Mar; 8(2):92-6. PubMed ID: 177348 [TBL] [Abstract][Full Text] [Related]
39. Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. Quesada I; Nadal A; Soria B Diabetes; 1999 Dec; 48(12):2390-7. PubMed ID: 10580428 [TBL] [Abstract][Full Text] [Related]
40. [The role of cyclic AMP in the control of insulin secretion (author's transl)]. Cerasi E; Grill V MMW Munch Med Wochenschr; 1977 Sep; 119(38):1229-36. PubMed ID: 198651 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]